The second edition of Stem Cells: Scientific Facts and Fiction provides the non-stem cell expert with an understandable review of the history, current state of affairs, and facts and fiction of the promises of stem cells. Building on success of its award-winning preceding edition, the second edition features new chapters on embryonic and iPS cells and stem cells in veterinary science and medicine. It contains major revisions on cancer stem cells to include new culture models, additional interviews with leaders in progenitor cells, engineered eye tissue, and xeno organs from stem cells, as well as new information on "organs on chips" and adult progenitor cells.
In the past decades our understanding of stem cell biology has increased tremendously. Many types of stem cells have been discovered in tissues that everyone presumed were unable to regenerate in adults, the heart and the brain in particular. There is vast interest in stem cells from biologists and clinicians who see the potential for regenerative medicine and future treatments for chronic diseases like Parkinson's, diabetes, and spinal cord lesions, based on the use of stem cells; and from entrepreneurs in biotechnology who expect new commercial applications ranging from drug discovery to transplantation therapies.
- Explains in straightforward, non-specialist language the basic biology of stem cells and their applications in modern medicine and future therapy
- Includes extensive coverage of adult and embryonic stem cells both historically and in contemporary practice
- Richly illustrated to assist in understanding how research is done and the current hurdles to clinical practice
Inhaltsverzeichnis
1;Front Cover;1 2;Stem Cells: Scientific Facts and Fiction;4 3;Copyright Page;5 4;Contents;6 5;Preface;10 6;Acknowledgements;12 7;1 The Biology of the Cell;14 7.1;1.1 Organisms Composition;15 7.2;1.2 Deoxyribonucleic Acid, Genes, and Chromosomes;17 7.3;1.3 How the Amount of Messenger Ribonucleic Acid is Regulated;24 7.4;1.4 From Messenger Ribonucleic Acid to a Functional Protein;27 7.5;1.5 From Deoxyribonucleic Acid and Proteins to a Cell with a Specific Function;28 7.5.1;1.5.1 Epigenetic Regulation;30 7.5.2;1.5.2 Ribonucleic Acid Interference;33 7.6;1.6 Deoxyribonucleic Acid Differences Between Genomes;33 7.7;1.7 Diseases Due to Variations and Genome Mutations;34 7.8;1.8 Dominant or Recessive;35 7.9;1.9 Deoxyribonucleic Acid Outside the Nucleus: Bacterial Remains;35 7.10;1.10 Cell Lines and Cell Culture;40 8;2 Embryonic Development;46 8.1;2.1 Fertilization and Early Embryo Development;56 8.2;2.2 Sex Cells and Germ Cell Tumors;63 9;3 What Are Stem Cells?;66 9.1;3.1 What are the Properties of Stem Cells That Make Them Different from Other Cells?;67 9.2;3.2 Totipotency and Pluripotency, and Embryonic Stem Cells;70 9.3;3.3 Multipotency, Unipotency, and Adult Stem Cells;75 9.4;3.4 Cell Division and Aging: The Role of Telomerase;76 9.5;3.5 The Relationship Between Cell Division and Differentiation: Epigenetics;76 9.6;3.6 Epigenetics in Stem Cells;79 10;4 Of Mice and Men: The History of Embryonic Stem Cells;82 10.1;4.1 How it All Began: Pluripotent Cells in Early Embryos;83 10.2;4.2 Mouse Embryonal Carcinoma Cell Lines;86 10.3;4.3 Pluripotent Cells in an Early Embryo;90 10.4;4.4 Mouse Embryonic Stem Cell Lines;92 10.5;4.5 Toward Human Embryonic Stem Cells;96 10.6;4.6 On the Road to Stem Cell Therapy;103 10.7;4.7 Biased Interpretation;105 10.8;4.8 The Future: Stem Cell Transplantation as a Clinical Treatment;106 10.9;4.9 Breakthrough of the Decade in the Twenty-First Century: Induced Pluripotent Stem Cells;107 11;5 Origins and Types of Stem Cells: Whats in a Name?;114 11.1
;5.1 Pluripotent Stem Cells;115 11.1.1;5.1.1 Embryonal Carcinoma Cells;115 11.1.2;5.1.2 Embryonic Stem Cells;117 11.1.3;5.1.3 Embryonic Germ Cells;124 11.1.4;5.1.4 Spermatogonial Stem Cells;128 11.1.5;5.1.5 Induced Pluripotent Stem Cells;132 11.2;5.2 Multipotent Stem Cells;134 11.2.1;5.2.1 Bone Marrow;136 11.2.2;5.2.2 Umbilical Cord Blood;138 12;6 Cloning: History and Current Applications;144 12.1;6.1 Before Dolly;145 12.2;6.2 Cloning Pets: Snuppy, Missy, and Copycat;161 12.3;6.3 Just Imagine What Could Be;165 12.4;6.4 Cloning Domestic Livestock;170 12.5;6.5 Cloning Challenges;171 13;7 Regenerative Medicine: Clinical Applications of Stem Cells;176 13.1;7.1 Therapeutic Cell Transplantation;182 13.2;7.2 Number of Cells Needed for Cell Transplantation;185 13.3;7.3 Why Some Diseases will be Treatable with Stem Cells in the Future and Others Not;187 13.3.1;7.3.1 Loss of One Cell Type or More Cell Types;189 13.3.2;7.3.2 Inherited and Acquired Diseases;191 13.3.3;7.3.3 Diabetes Type 1: An Autoimmune Disease;193 13.3.4;7.3.4 Spinal Cord Injury and Multiple Sclerosis: Restoring Demyelination;195 13.3.5;7.3.5 Macular Degeneration: The Ideal Disease;197 13.3.6;7.3.6 Deafness;199 13.4;7.4 The Best Stem Cells for Transplantation;202 13.5;7.5 Combining Gene Therapy with Stem Cell Transplantation;206 13.6;7.6 Where to Transplant Stem Cells and Their Effect;209 13.7;7.7 Cell Types Available for Cell Transplantation;214 13.7.1;7.7.1 Adult Stem Cells;214 13.7.2;7.7.2 Embryonic and Induced Pluripotent Stem Cells;216 13.8;7.8 Transplantation of Stem Cells: Where We Stand;219 13.9;7.9 Risks Associated with a Stem Cell Transplantation;224 13.10;7.10 Stem Cells Rejected After Transplantation;227 13.10.1;7.10.1 How the Bodys Immune System Recognizes a Cell as Foreign;228 13.10.2;7.10.2 Reverse Rejection: Graft-Versus-Host;231 13.10.3;7.10.3 How to Prevent Rejection of a Cell Transplant;234 13.11;7.11 Tissue Engineering;239 14;8 Stem Cells in Veterinary Medicine;248 14.1;8.1 Treatment of Fa
mily Pets;250 14.1.1;8.1.1 Tendon in the Horse;251 14.1.2;8.1.2 Osteoarthritis in Dogs;254 14.1.3;8.1.3 Induced Pluripotent Stem Cells;257 15;9 Cardiomyocytes from Stem Cells: What Can We Do with Them?;260 15.1;9.1 The Heart and Cardiac Repair;264 15.2;9.2 From Pluripotent Stem Cells to Cardiomyocytes;276 16;10 Adult Stem Cells: Generation of Self-Organizing Mini-Organs in a Dish;292 16.1;10.1 Adult Stem Cells in Internal Organs;293 16.2;10.2 Adult Stem Cells in the Intestine;296 16.3;10.3 Adult Stem Cells in Muscle Tissue;299 16.4;10.4 What We Have Learnt About Adult Stem Cells;301 16.5;10.5 The Future: Organoids to Repair Tissues and Organs;302 17;11 Stem Cell Tourism;304 17.1;11.1 Definition of Stem Cell Tourism;305 17.2;11.2 What's the Difference Between Trials and Treatment?;311 17.3;11.3 Perspective of the International Society for Stem Cell Research;326 18;12 Cancer Stem Cells: Where Do They Come From and Where Are They Going?;328 18.1;12.1 Cancer: Observations and Questions;329 18.2;12.2 Introduction to Stem Cells and Cancer;330 18.2.1;12.2.1 A Brief History of Cancer Stem Cells;331 18.3;12.3 The Behavior of Cancer Cells: Not All Tumors and Not All Cells Within a Tumor Look the Same;334 18.3.1;12.3.1 A Darwinian View: Evolution of a Tumor;335 18.4;12.4 Colon Adenoma: A Case in Point for the Role of an Adult Stem Cell as the Stem Cell of Origin;336 18.4.1;12.4.1 Development of a Colon Adenoma;336 18.4.2;12.4.2 When Does a Tumor Become Malignant and Metastasize to Different Organs?;339 18.4.3;12.4.3 Interaction between Cancer Cells and Their Environment Leads to Phenotypic Heterogeneity;340 18.5;12.5 How to Become a Cancer Stem Cell: Epithelial Mesenchymal Transition;347 18.6;12.6 How Developmental Signal Transduction Pathways Become Active in Cancer Cells;348 18.7;12.7 Cancer Stem Cells as Circulating Tumor Cells;350 18.8;12.8 The Final Step: Initiation of Metastatic Growth;350 18.9;12.9 A Cancer Stem Cell: Can it Differentiate to Another Cell Type?;351 18.10
;12.10 Cancer Stem Cells: Development of New Drugs to Treat Cancer;352 18.11;12.11 Conclusions and Research Challenges;354 19;13 Human Stem Cells for Organs-on-Chips: Clinical Trials Without Patients?;356 19.1;13.1 Introduction;357 19.2;13.2 Organs-on-Chips;358 19.3;13.3 Why We Need Human Organ and Disease-on-Chip Models;361 19.4;13.4 Human Organ-on-a-Chip Models for Certain Diseases;364 19.5;13.5 Human Disease Models as Organs-on-Chips: Challenges;365 19.6;13.6 Where We are Now with Organ-on-a-Chip Technology;365 19.6.1;13.6.1 Pluripotent or Adult Stem Cells;368 19.6.2;13.6.2 Organ-on-a-Chip Technology to Mediate Formation of Functional Tissues and Organs;369 19.7;13.7 Applications of Organs-on-Chips;371 19.7.1;13.7.1 Model Systems for Drug Toxicity Screening;372 19.7.2;13.7.2 Human Disease Models for Drug Target Discovery and Drug Development: A Role for Organs-on-Chips;372 19.8;13.8 Conclusion;373 20;14 Stem Cells for Discovery of Effective and Safe New Drugs;376 20.1;14.1 Drug Discovery: A Short Historical Perspective;377 20.2;14.2 Modern Drug Discovery;380 20.3;14.3 Challenges and Opportunities in Drug Discovery;382 20.4;14.4 How the Safety of New Drugs is Secured;388 20.5;Acknowledgments;390 21;15 Patents, Opportunities, and Challenges: Legal and Intellectual Property Issues Associated with Stem Cells;394 21.1;15.1 Companies and Alliances;397 21.2;15.2 Patent Issues: Current Intellectual Property Landscape;398 21.2.1;15.2.1 Wisconsin Alumni Research Foundation;399 21.3;15.3 Europe Versus the United States;400 21.4;15.4 More Legal and Ethical Issues;406 21.4.1;15.4.1 Privacy and Ownership;407 21.5;Acknowledgments;408 21.6;Further Reading;408 22;16 Stem Cell Perspectives: A Vision of the Future;410 22.1;16.1 Combining Technologies: New Human Disease Models for Drug Discovery;415 22.2;16.2 Personalized Medicine and Safer Drugs;417 22.3;16.3 Final Note;419 23;Glossary;422 24;Index;430 25;Photo Credits;440